Reinforcement of the Global Management System ■  Compensation of Directors and Corporate Auditors Business Execution Committees Top Management Structure  Astellas Pharma Inc.  _ Annual Report 2014 78 With a basic policy of contributing to continued growth of  business results and improved enterprise value of the  Company, the compensation paid to Directors and  Corporate Auditors of the Company is designed to enable  the Company to attract and retain competent persons, and  maintain sufficient compensation standards and system to  meet the duties and responsibilities of the Directors and  Corporate Auditors. In establishing compensation stan- dards, the Company has improved objectivity by using,  among other things, research data issued by an outside  research company. Compensation paid to Directors consists of three com- ponents, namely, basic fixed compensation, bonuses and  stock options. Outside Directors receive only basic fixed  compensation. Corporate Auditors (including outside  Corporate Auditors) receive only basic fixed compensation. * The total amount of compensation shown here is the amount paid as  compensation for the performance of duties during fiscal 2013, and  includes the amount paid to those of three Directors (including two outside  Directors) and one Corporate Auditor who retired during fiscal 2013. Top management and the officers responsible for each  of the functions and regions attend Global Management  Committee meetings. Astellas also has committees respon- sible for other aspects of business execution. They are the  CSR Committee, the Global Compliance Committee, the  Risk Management Committee, and the IR Committee. In order to respond quickly to changes in the business  environment and to make quicker and more appropriate  decisions, Astellas is promoting a “matrix management”  structure that consists of a functional axis—covering the  functions of Drug Discovery Research, Medical and   Development, and Technology—as well as a geographical  region axis covering the sales & marketing function. The Company has established the Global Management  Committee, the Corporate Administration & Finance   Committee, and the Global Human Resources Committee  to ensure the smooth execution of business at a global  level. These committees discuss important matters related  to global management, finance, accounting and corporate  administration, and human resources, respectively. (¥ million) Type of Compensation* Total  Compensation* Base  Salary Stock  Options Bonus Directors (excluding outside  Directors): 4 511 284 112 114 Corporate Auditors (excluding  outside Corporate Auditors): 3 88 88 — — Outside Directors and outside  Corporate Auditors: 8 72 72 — — Current Position Department in-charge President and CEO Yoshihiko Hatanaka Internal Auditing, Medical Affairs, Drug Discovery  Research, Technology, Sales & Marketing, Asia/ Oceania Business, EMEA Operations, Americas  Operations Executive Vice President Yoshiro Miyokawa External Relations, General Affairs, Human  Resources, Legal & Compliance, Executive  Office Chief Financial Officer Yasumasa Masuda Corporate Finance & Control, Accounting & Tax,  Corporate Communications, Procurement,  Information Systems Chief Strategy Officer Kenji Yasukawa,  Ph.D. Corporate Planning, Product and Portfolio  Strategy, Licensing & Alliances, Innovation  Management, Intellectual Property Chief Medical Officer Sef Kurstjens,  M.D., Ph.D. Global Development, Global Pharmacovigilance,  Global Medical Affairs, Global Regulatory Affairs,  Global Clinical and Research Quality Assurance,  Global Quality Assurance Committee Name/ Chairman Role Global Management  Committee/  President and CEO Discusses important matters pertaining to  product strategy as well as management-related  matters, such as research, development,  technology, and sales and marketing. Corporate  Administration &  Finance Committee/ Executive Vice  President Discusses important matters concerning finance,  accounting and corporate administration. Global Human  Resources  Committee/  President and CEO Discusses appointment and dismissal of  Corporate Executives, department general  managers, and important positions in Group  companies as well as other important matters  concerning human resources. CSR Committee/  Chief Strategy Officer Discusses matters pertaining to CSR initiatives  for Astellas as a whole. Global Compliance  Committee/Executive  Vice President Discusses policies and plans concerning  compliance covering the whole of Astellas as  well as important matters concerning compliance. Risk Management  Committee/Executive  Vice President Discusses important policies, measures and  other matters for promoting risk management. IR Committee/  Chief Financial Officer Discusses investor relations (IR) activity policies  and plans as well as the formulation, revision,  and other matters concerning the Company’s  corporate disclosure policy.